Article - Frank Amato
Early, Accurate Alzheimer’s Disease Diagnosis Critical for Avoiding the Often-Devastating Impact of Misdiagnosis- By Frank Amato, President and CEO, SYNAPS Dx
Mr. Frank Amato writes, "New methods of diagnosis are needed now more than ever. The most promising breakthrough for identifying Alzheimer's Disease is an autopsy-confirmed, minimally invasive skin test to support clinicians’ definitive diagnosis of AD vs. other forms of dementia. This test has the potential to help patients and families get the right support or treatment path for improved quality of life. Learn more.